Mon, June 13, 2011
Fri, June 10, 2011
Thu, June 9, 2011
Wed, June 8, 2011
Tue, June 7, 2011
Mon, June 6, 2011
Sat, June 4, 2011
Fri, June 3, 2011
Thu, June 2, 2011
Wed, June 1, 2011
Tue, May 31, 2011
Mon, May 30, 2011
Fri, May 27, 2011
Thu, May 26, 2011
Wed, May 25, 2011
Tue, May 24, 2011
Mon, May 23, 2011
Sun, May 22, 2011
Fri, May 20, 2011
Thu, May 19, 2011
Wed, May 18, 2011
Tue, May 17, 2011
Mon, May 16, 2011
Sun, May 15, 2011
[ Sun, May 15th 2011 ] - Market Wire
Teva to Acquire Taiyo
Fri, May 13, 2011
Thu, May 12, 2011

AMAG Pharmaceuticals Announces Resignation of Chief Financial Officer


//health-fitness.news-articles.net/content/2011/ .. nces-resignation-of-chief-financial-officer.html
Published in Health and Fitness on Wednesday, May 25th 2011 at 13:40 GMT by Market Wire   Print publication without navigation


LEXINGTON, Mass.--([ BUSINESS WIRE ])--AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia, today announced that David Arkowitz, AMAGa™s executive vice president, chief financial officer and chief business officer, has resigned to pursue an opportunity at a private biofuels company. Mr. Arkowitz will remain with AMAG through June 24th.

"Ted has worked closely with David to build a strong accounting and financial reporting organization since joining AMAG in 2007"

"Over the past four years, David has played an integral role in the establishment of AMAG as a commercial biopharmaceutical company," said Brian J.G. Pereira, chief executive officer of AMAG. "We are thankful for his contributions and wish him success in his new endeavor."

Edward (Ted) C. English, age 44, AMAGa™s vice president and corporate controller, will serve as interim chief financial officer until a national search for a new chief financial officer is complete. Mr. English has been with AMAG since 2007. From 1997 to 2007, Mr. English served in various senior financial positions with increasing responsibility at Praecis Pharmaceuticals, Inc., culminating in his appointment as vice president, chief financial officer and treasurer in 2004. Mr. English holds a B.S. in Business Administration from Georgetown University and a joint M.S. in Accounting and M.B.A. from the Northeastern University Graduate School of Professional Accounting. Mr. English will continue to serve as the companya™s vice president and corporate controller during his service as interim chief financial officer.

aTed has worked closely with David to build a strong accounting and financial reporting organization since joining AMAG in 2007,a Pereira continued. aI am confident that Ted and the finance team will continue to provide the support and discipline required of a public, commercial organization.a

About AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. For additional company information, please visit [ www.amagpharma.com ].


Publication Contributing Sources